Spring Bank Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.56 |
Market Cap |
$82.71 M |
Shares Outstanding |
16.44 M |
Public Float |
13.42 M |
Address |
35 Parkwood Drive Hopkinton Massachusetts 01748 United States |
Employees | - |
Website | http://www.springbankpharm.com |
Updated | 07/08/2019 |
Spring Bank Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its pipeline include RIG-I & STING Agonists platforms. The company was founded by Douglas J. |